Monte Rosa Therapeutics
GLUE
GLUE
71 hedge funds and large institutions have $201M invested in Monte Rosa Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 68 → 71 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
26% less capital invested
Capital invested by funds: $272M → $201M (-$70.9M)
Holders
71
Holding in Top 10
2
Calls
$1.36M
Puts
$580K
Top Buyers
| 1 | +$9.06M | |
| 2 | +$3.8M | |
| 3 | +$367K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$343K |
| 5 |
Two Sigma Investments
New York
|
+$320K |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$794K | |
| 3 | -$241K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$213K |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$147K |